The aim of this application is to facilitate the development of a breast cancer program at the Johns Hopkins Medical institutions that will integrate basic research findings with clinical studies to provide new directions for achieving enhanced prevention, early diagnosis, and treatment of breast cancer. The new program would address four broad goals: l) to foster the development of a broad-based basic science program addressing molecular determinants of breast cancer development and progression and response/resistance to therapy; 2) to enhance ongoing efforts to improve the efficacy and/or decrease the toxicity of systemic therapy through institutional pilot trials that are based on or integrated with laboratory findings and continue participation in cooperative group trials; 3) to lay the foundation for a comprehensive laboratory and clinical program in the area of breast cancer prevention and risk assessment; and 4) to improve existing efforts to provide access to breast cancer research opportunities in prevention, early diagnosis and treatment, particularly to residents of Maryland and the city of Baltimore. Resources from this planning grant would be used to achieve these goals through support of a program: director, funding for an internal pilot grant program, recruitment of a new junior faculty member who wishes to establish an independent laboratory program in the breast cancer field, and support for an annual scientific retreat. The ultimate goal is to foster the development of a self-sustaining and productive translational research program

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21CA066204-02
Application #
2109492
Study Section
Special Emphasis Panel (SRC (05))
Project Start
1994-09-30
Project End
1998-09-29
Budget Start
1995-09-30
Budget End
1996-09-29
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Goodman, J E; Lavigne, J A; Wu, K et al. (2001) COMT genotype, micronutrients in the folate metabolic pathway and breast cancer risk. Carcinogenesis 22:1661-5
Wu, K; Helzlsouer, K J; Alberg, A J et al. (2000) A prospective study of plasma ascorbic acid concentrations and breast cancer (United States). Cancer Causes Control 11:279-83
Anbazhagan, R; Fujii, H; Gabrielson, E (1999) Microsatellite instability is uncommon in breast cancer. Clin Cancer Res 5:839-44
Wu, K; Helzlsouer, K J; Comstock, G W et al. (1999) A prospective study on folate, B12, and pyridoxal 5'-phosphate (B6) and breast cancer. Cancer Epidemiol Biomarkers Prev 8:209-17
Anbazhagan, R; Fujii, H; Gabrielson, E (1998) Allelic loss of chromosomal arm 8p in breast cancer progression. Am J Pathol 152:815-9
Ravi, R; Mookerjee, B; van Hensbergen, Y et al. (1998) p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300. Cancer Res 58:4531-6
Fujii, H; Zhou, W; Gabrielson, E (1996) Detection of frequent allelic loss of 6q23-q25.2 in microdissected human breast cancer tissues. Genes Chromosomes Cancer 16:35-9
Fujii, H; Szumel, R; Marsh, C et al. (1996) Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast. Cancer Res 56:5260-5
Fujii, H; Marsh, C; Cairns, P et al. (1996) Genetic divergence in the clonal evolution of breast cancer. Cancer Res 56:1493-7